Abstract
The debate over the provision of sterile injection equipment to intravenous drug users, as a means of preventing the spread of the AIDS epidemic, has a number of political, ethical, and clinical implications. The issue has in some respects been inappropriately dichotomized as a conflict between public health agendas and the traditional priorities of drug treatment. The relevant issues include: (1) the existence of evidence for needle-sharing as a route of transmission of human immunodeficiency virus among intravenous drug users; (2) the role of needle scarcity as a factor promoting needle-sharing behavior, and evidence for the ability of drug users to change such behavior; (3) the possibility of increased needle availability leading to increased prevalence of intravenous drug abuse; (4) the possibility that the provision of sterile needles would compromise treatment efforts among drug abusers currently or potentially engaged in the treatment system. These issues are discussed in light of relevant existing data; a multilevel strategy for AIDS prevention among drug users is suggested, addressing both the availability of sterile injection equipment and the promotion of drug treatment goals.
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
